VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2024 SESSION

SB 614 Xylazine; penalty for manufacturing, selling, etc., for human consumption.

---

01/10/24 Senate: Prefiled and ordered printed; offered 01/10/24 24104627D

• 01/12/24 Senate: Impact statement from VCSC (SB614)
  
• 01/25/24 Senate: Impact statement from DPB (SB614)
  

02/01/24 Senate: Committee substitute printed 24106043D-S1

• 02/02/24 Senate: Impact statement from VCSC (SB614S1)
  
• 02/05/24 Senate: Impact statement from DPB (SB614S1)
  

02/29/24 Senate: Bill text as passed Senate and House (SB614ER)

• 02/29/24 Senate: Impact statement from DPB (SB614ER)